Company Search:
Advanced Search
Sponsored Links
Takeda Pharmaceutical Company Limited Company Snapshot
Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other companies in this sector in Japan: Astellas Pharma Incorporated (2016 sales of 1.37 trillion Japanese Yen [US$12.35 billion] of which 57% was Other), Otsuka Holdings Company Limited (1.20 trillion Japanese Yen [US$10.76 billion] ), and Daiichi Sankyo Company Limited (986.45 billion Japanese Yen [US$8.88 billion] of which 94% was prescription drugs).

Sales Analysis. Takeda Pharmaceutical Company Limited reported sales of ¥1.81 trillion (US$16.27 billion) for the fiscal year ending March of 2016. This represents a very small increase of 1.7% versus 2015, when the company's sales were ¥1.78 trillion. Sales at Takeda Pharmaceutical Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 27%). Sales of Healthcare saw an increase that was more than double the company's growth rate: sales were up 8.9% in 2016, from ¥73.58 billion to ¥80.09 billion. Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2016: sales of Other fell 12.4% to ¥78.61 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Takeda Pharmaceutical Company Limited
  Stock Performance Chart for Takeda Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 5,262.00
(Figures in Japanese Yen)
1 Week -1.0%   13 Weeks -1.6%  
4 Weeks 9.0%   52 Weeks -3.0%  
Takeda Pharmaceutical Company Limited Key Data:
  Ticker: 4502 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,807,378,000,000
(Year Ending Jan 2017).
Employees: 31,168
  Currency: Japanese Yen Market Cap: 4,108,149,013,602
  Fiscal Yr Ends: March Shares Outstanding: 780,720,071
  Share Type: Common Closely Held Shares: 21,141,729
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.